The current valuation score of Canopy Growth Corp is 7.75, ranking 122 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -0.66, which is -89.70% below the recent high of -0.07 and -337.28% above the recent low of -2.87.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.